Antiplatelets & Anticoagulation Drugs: Dental Implications
Antiplatelets & Anticoagulation Drugs: Dental Implications Dr Parmanand Dhanrajani (dan.dhanrajani@gmail.com) - BDS, MDS, MSc, MSC, FRACDS, FDSRCS, FFDRCSI Oral Surgeon Dr Patrick Chung - Consultant anaesthetist MB BS (1st Class Hons), FANZCA Dr Mark Smith - BDS Manager, Clinical Quality and Safety Dr Christopher Ho - BDS, Dentist Dental News Magazine - June 2018 issue Abstract Many patients with cardiovascular disorder, including coronary heart disease, cerebrovascular disease, atrial fibrillation and venous throm-boembolic disease, take antiplatelet and/or anticoagulant drugs. Over the last five decades warfarin has been the oral anticoagulant of choice and has been considered as mainstay of treatment. However, the frequent requirement for monitoring and multiple drug and food interactions have fuelled the need for development of newer oral anticoagulants. As a direct result of this, a new generation of oral anticoagul...